Literature DB >> 30448285

Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice.

Andrew E Arrant1, Anthony J Filiano1, Aashka R Patel1, Madelyn Q Hoffmann1, Nicholas R Boyle1, Shreya N Kashyap1, Vincent C Onyilo1, Allen H Young1, Erik D Roberson2.   

Abstract

Loss-of-function mutations in progranulin (GRN), most of which cause progranulin haploinsufficiency, are a major autosomal dominant cause of frontotemporal dementia (FTD). Individuals with loss-of-function mutations on both GRN alleles develop neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disorder. Progranulin is a secreted glycoprotein expressed by a variety of cell types throughout the body, including neurons and microglia in the brain. Understanding the relative importance of neuronal and microglial progranulin insufficiency in FTD pathogenesis may guide development of therapies. In this study, we used mouse models to investigate the role of neuronal and microglial progranulin insufficiency in the development of FTD-like pathology and behavioral deficits. Grn-/- mice model aspects of FTD and NCL, developing lipofuscinosis and gliosis throughout the brain, as well as deficits in social behavior. We have previously shown that selective depletion of neuronal progranulin disrupts social behavior, but does not produce lipofuscinosis or gliosis. We hypothesized that reduction of microglial progranulin would induce lipofuscinosis and gliosis, and exacerbate behavioral deficits, in neuronal progranulin-deficient mice. To test this hypothesis, we crossed Grnfl/fl mice with mice expressing Cre transgenes targeting neurons (CaMKII-Cre) and myeloid cells/microglia (LysM-Cre). CaMKII-Cre, which is expressed in forebrain excitatory neurons, reduced cortical progranulin protein levels by around 50%. LysM-Cre strongly reduced progranulin immunolabeling in many microglia, but did not reduce total brain progranulin levels, suggesting that, at least under resting conditions, microglia contribute less than neurons to overall brain progranulin levels. Mice with depletion of both neuronal and microglial progranulin failed to develop lipofuscinosis or gliosis, suggesting that progranulin from extracellular sources prevented pathology in cells targeted by the Cre transgenes. Reduction of microglial progranulin also did not exacerbate the social deficits of neuronal progranulin-insufficient mice. These results do not support the hypothesis of synergistic effects between progranulin-deficient neurons and microglia. Nearly complete progranulin deficiency appears to be required to induce lipofuscinosis and gliosis in mice, while partial progranulin insufficiency is sufficient to produce behavioral deficits.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavior; Frontotemporal dementia; Lysosome; Microglia; Neuron; Neuronal ceroid lipofuscinosis; Pathology; Progranulin

Mesh:

Substances:

Year:  2018        PMID: 30448285      PMCID: PMC6363848          DOI: 10.1016/j.nbd.2018.11.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  62 in total

1.  Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice.

Authors:  Hans Wils; Gernot Kleinberger; Sandra Pereson; Jonathan Janssens; Anja Capell; Debby Van Dam; Ivy Cuijt; Geert Joris; Peter P De Deyn; Christian Haass; Christine Van Broeckhoven; Samir Kumar-Singh
Journal:  J Pathol       Date:  2012-06-25       Impact factor: 7.996

2.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

3.  Reducing inflammation and rescuing FTD-related behavioral deficits in progranulin-deficient mice with α7 nicotinic acetylcholine receptor agonists.

Authors:  S Sakura Minami; Vivian Shen; David Le; Grietje Krabbe; Rustam Asgarov; Liberty Perez-Celajes; Chih-Hung Lee; Jinhe Li; Diana Donnelly-Roberts; Li Gan
Journal:  Biochem Pharmacol       Date:  2015-07-20       Impact factor: 5.858

4.  Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia.

Authors:  Brian A Warmus; Dheepa R Sekar; Eve McCutchen; Gerard D Schellenberg; Rosalinda C Roberts; Lori L McMahon; Erik D Roberson
Journal:  J Neurosci       Date:  2014-12-03       Impact factor: 6.167

5.  Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia.

Authors:  Fangfang Yin; Magali Dumont; Rebecca Banerjee; Yao Ma; Huihong Li; Michael T Lin; M Flint Beal; Carl Nathan; Bobby Thomas; Aihao Ding
Journal:  FASEB J       Date:  2010-07-28       Impact factor: 5.191

6.  Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.

Authors:  Zoe A Klein; Hideyuki Takahashi; Mengxiao Ma; Massimiliano Stagi; Melissa Zhou; TuKiet T Lam; Stephen M Strittmatter
Journal:  Neuron       Date:  2017-07-19       Impact factor: 17.173

7.  Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury.

Authors:  Katie Moisse; Kathryn Volkening; Cheryl Leystra-Lantz; Ian Welch; Tracy Hill; Michael J Strong
Journal:  Brain Res       Date:  2008-11-01       Impact factor: 3.252

8.  Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation.

Authors:  Hansen Lui; Jiasheng Zhang; Stefanie R Makinson; Michelle K Cahill; Kevin W Kelley; Hsin-Yi Huang; Yulei Shang; Michael C Oldham; Lauren Herl Martens; Fuying Gao; Giovanni Coppola; Steven A Sloan; Christine L Hsieh; Charles C Kim; Eileen H Bigio; Sandra Weintraub; Marek-Marsel Mesulam; Rosa Rademakers; Ian R Mackenzie; William W Seeley; Anna Karydas; Bruce L Miller; Barbara Borroni; Roberta Ghidoni; Robert V Farese; Jeanne T Paz; Ben A Barres; Eric J Huang
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

9.  Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice.

Authors:  Anthony J Filiano; Lauren Herl Martens; Allen H Young; Brian A Warmus; Ping Zhou; Grisell Diaz-Ramirez; Jian Jiao; Zhijun Zhang; Eric J Huang; Fen-Biao Gao; Robert V Farese; Erik D Roberson
Journal:  J Neurosci       Date:  2013-03-20       Impact factor: 6.167

10.  Progranulin haploinsufficiency causes biphasic social dominance abnormalities in the tube test.

Authors:  A E Arrant; A J Filiano; B A Warmus; A M Hall; E D Roberson
Journal:  Genes Brain Behav       Date:  2016-07       Impact factor: 3.449

View more
  4 in total

Review 1.  Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders.

Authors:  Todd E Golde
Journal:  Neuron       Date:  2019-03-20       Impact factor: 17.173

Review 2.  Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.

Authors:  Anarmaa Mendsaikhan; Ikuo Tooyama; Douglas G Walker
Journal:  Cells       Date:  2019-03-11       Impact factor: 6.600

3.  Microglia regulate brain progranulin levels through the endocytosis/lysosomal pathway.

Authors:  Tingting Dong; Leon Tejwani; Youngseob Jung; Hiroshi Kokubu; Kimberly Luttik; Terri M Driessen; Janghoo Lim
Journal:  JCI Insight       Date:  2021-11-22

4.  Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology.

Authors:  Anarmaa Mendsaikhan; Ikuo Tooyama; Jean-Pierre Bellier; Geidy E Serrano; Lucia I Sue; Lih-Fen Lue; Thomas G Beach; Douglas G Walker
Journal:  Acta Neuropathol Commun       Date:  2019-12-21       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.